RFNFX
Price
$86.52
Change
+$0.53 (+0.62%)
Updated
Jun 6 closing price
Net Assets
146.4B
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

RFNFX vs VITSX

Header iconRFNFX vs VITSX Comparison
Open Charts RFNFX vs VITSXBanner chart's image
American Funds Fundamental Invs R5
Price$86.52
Change+$0.53 (+0.62%)
VolumeN/A
Net Assets146.4B
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
RFNFX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RFNFX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RFNFX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. RFNFX (146B). VITSX (1.29) and RFNFX (1.24) have matching dividends . RFNFX was incepted earlier than VITSX: RFNFX (23 years) vs VITSX (28 years). RFNFX (0.33) is less costly to investors than VITSX (0.03). RFNFX is a more actively managed with annual turnover of: 28.00 vs. VITSX (2.00). RFNFX has a lower initial minimum investment than VITSX: RFNFX (250) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. RFNFX (8.86). VITSX return over 5 years is better than : 80.96 vs. RFNFX (51.64).
RFNFXVITSXRFNFX / VITSX
Total Expense Ratio0.330.031,100%
Annual Report Gross Expense Ratio0.330.031,100%
Fund Existence23 years28 years-
Gain YTD7.3840.833886%
Front LoadN/AN/A-
Min. Initial Investment25050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets146B1.82T8%
Annual Yield % from dividends1.241.2996%
Returns for 1 year8.8610.9781%
Returns for 3 years33.2340.3582%
Returns for 5 years51.6480.9664%
Returns for 10 years70.22180.4939%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.